Evidence map›Paper›PMID 34366849›Full record

ArticleFrontiers in pharmacology2021

Glycoproteins From

An-Qi Ren, Hui-Jun Wang, Hai-Yan Zhu, Guan Ye, Kun Li, Dao-Feng Chen, Tao Zeng, Hong Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

An-Qi RenDepartment of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
Hui-Jun WangThe MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Hai-Yan ZhuDepartment of Biological Medicines and Shanghai Engineering Research Center of Immuno Therapeutics, School of Pharmacy, Fudan University, Shanghai, China.
Guan YeCentral Research Institute, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai, China.
Kun LiCentral Research Institute, Shanghai Pharmaceuticals Holding Co., Ltd., Shanghai, China.
Dao-Feng ChenDepartment of Pharmacognosy, School of Pharmacy, Fudan University, Shanghai, China.
Tao ZengClinical Trial Institution, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Hong LiDepartment of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
Fudan University · CNObstetrics and Gynecology Hospital of Fudan University · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acute lung injuryglycoproteinsinflammationmacrophage polarizationRabdosia japonica var glaucocalyxTLR4/NF-κB signal pathway

Identifiers

PMID34366849
PMCPMC8333617
OpenAlexW3185764098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.